1. Stats
  2. USPTO
  3. TC 1600
  4. Group 1630
  5. Art Unit 1638
  6. Examiner Amick

Examiner Amick Thomas R

1638-AMICK-THOMAS-R

Employment Information

Art Unit:1638 — Drug, bio-affecting and body treating compositions
Group:1630 — Stem cells and cell culture and Nucleic Acid related therapy
Classes: 424 — Drug, bio-affecting and body treating compositions
435 — Chemistry: molecular biology and microbiology
800 — Multicellular living organisms and unmodified parts thereof and related processes
514 — Drug, bio-affecting and body treating compositions
Phone:(571) 272-5474
Email:thomas.amick@uspto.gov
Location:VA 22314
Title:Pat Examnr (Biology)
Service:4 years
Grade:GS-09

Grant Rate and Difficulty Ranking

87
3-Year Grant rate: 39% over 28 cases
Difficulty: Very Hard
Difficulty Percentile: 87th

With Examiner Amick, you have a 39% chance of getting an issued patent by 3 years after the first office action. Examiner Amick is a very hard examiner and in the 87th percentile across all examiners (with 100th percentile most difficult).

Grant Rate

Grant Rate Timeline

Below is the grant rate timeline for Examiner Amick, where the timeline is relative to the date of the first office action. The three-year grant rate is the percentage of applications granted at three years after the first office action.

Comparison with Art Unit 1638

Examiner Amick's grant rate is lower than that of Art Unit 1638 and lower than that of the USPTO.

Average Office Actions Per Grant
Examiner Amick 2.1
Art Unit 1638 2.1

Interview Benefit

Grant Rate without Interview

Examiner Amick has granted 9 of 24 cases without any applicant-requested interviews for a grant rate of 38%.

Grant Rate with Interview

Examiner Amick has granted 2 of 4 cases with at least one applicant-requested interview for a grant rate of 50%.

Interview Benefit

With Examiner Amick, conducting an interview increases your chance of getting a patent granted by 32%.

Recent Dispositions

Recent Dispositions

Number Title OA Rejections Status IFW
17716029 Injectable Off-The- Shelf Cartilage, Tendon, And Ligament Repair Compositions And Methods Of Use Rejection information available with a Premium Stats subscription. See our pricing. Patented View
17932857 Enhancing Anti-Tumor Response In Melanoma Cells With Defective Sting Signaling Patented View
17613586 Autologous Cell Replacement Therapy For Parkinson`s Disease Patented View
17421287 Improved Targeted T-Cell Therapy For Treatment Of Multiple Myeloma Patented View
17435485 Genome-Edited Birds Patented View
16092841 Methods For Creating Synthetic Chromosomes Having Gene Regulatory Systems And Uses Thereof Patented View
17910931 Targeted Chimeric Antigen Receptor Modified T Cells For Treatment Of Il13ralpha2 Positive Malignancies Patented View
17790041 Method For Purifying Ucart Cell And Use Thereof Abandoned View
16978407 Injectable Off-The- Shelf Cartilage, Tendon, And Ligament Repair Compositions And Methods Of Use Patented View
17425498 Compositions And Methods For Targeting Mutant Ras Patented View
17232588 Systems And Methods For Immobilizing Extracellular Matrix Material On Organ On Chip, Multilayer Microfluidics Microdevices, And Three-Dimensional Cell Culture Systems Patented View
19228304 Gene Therapy To Improve Vision Abandoned View
16993692 Method For Inducing Rna Silencing Patented View
17397174 Materials And Methods For Producing Bioengineered Virus Specific Lymphocytes Patented View
18672944 Compositions And Methods Of Expansion Of T Cell Populations Abandoned View
17780945 Compositions And Methods For The Targeting Of Rhodopsin Abandoned View
17904223 Use Of Early Apoptotic Cells For Treating Covid-19 Abandoned View
17780617 Method For Obtaining Car-Nk Cells Abandoned View
17617632 Circular Rnas For Cellular Therapy Abandoned View
17237087 Clinical Gene Signature-Based Human Cell Culture Model And Uses Thereof Patented View
17614421 Cd8+ T-Cells Lacking Plexins And Their Application In Cancer Treatment Patented View
17277142 Chemokine Expressing Cell And Use Thereof Abandoned View
17416739 Transgenic Mouse Expressing Common Human Light Chain Patented View
16476628 Modified T Cells And Methods Of Their Use Patented View
17600987 Serum-Free Cryopreservation Solution And Preparation Method And Application Thereof Patented View
17611542 Engineered Immune Cells Comprising A Recognition Molecule Abandoned View
17593391 Preparation And Storage Of Liposomal Rna Formulations Suitable For Therapy Patented View
17279697 Polynucleotides Encoding Arginase 1 For The Treatment Of Arginase Deficiency Abandoned View
17057206 Cell Therapy Abandoned View
17415957 Production And Therapeutic Use Of Off-The-Shelf Double Negative T Cells Abandoned View
17862797 Methods For Enhancing Efficacy Of Therapeutic Immune Cells Patented View
16943400 Methods For Enhancing Efficacy Of Therapeutic Immune Cells Patented View
17254094 Antibody Capable Of Inducing Immune Tolerance Produced Using Cell Mixture Having Complexed State, And Induced Lymphocyte Or Cell Therapeutic Agent And Cell Therapy Method Each Using Induced Lymphocyte Patented View
16978735 Compositions And Methods For Treating Age-Related Macular Degeneration Patented View
17609507 Targeting Otub1 In Immunotherapy Abandoned View
16931986 Lentiviral Vectors For Regulated Expression Of A Chimeric Antigen Receptor Molecule Abandoned View
17127496 Animal Model For Hepatocellular Carcinoma And Uses Thereof Patented View
17083211 Treatment Of Cancer Using A Cd33 Chimeric Antigen Receptor Patented View
17857495 Mesenchymal Stem Cells For Use In The Treatment Of Atopic Dermatitis Patented View
17251666 Mitochondrial Augmentation Therapy Of Renal Diseases Patented View
17311210 Biomarker Abandoned View
16965955 Icam-1 Marker And Application Thereof Abandoned View
17045562 Humanized Mouse Model Abandoned View
16335884 Method For Preparing A Supplement From Mesenchymal Cell Cultures Of Wharton's Jelly And Uses Of Same Abandoned View
16980782 Macrophage-Based Therapy Patented View
17619158 Cd52-Deficient Cells For Adoptive Cell Therapy Abandoned View
16302865 Gene Therapy Methods For Age-Related Diseases And Conditions Patented View
18459302 Methods Of Use For Car T Cells Patented View
16658197 Culture System And Media For Skin Explants Providing Enhanced Viability And Enabling Molecular Studies Patented View
17254110 Method For Eliciting Infectious Immunological Tolerance Patented View

Appeals Statistics

Purchase Subscription

Subscribe to Premium Examiner Statistics for unlimited access for your law firm.

Disclaimer: We do not provide any guarantees as to the accuracy of the statistics presented above and under
no circumstances will we be liable for any outcome resulting from your reliance on the above statistics.